PT - JOURNAL ARTICLE AU - Bhagat, Nikunj AU - Yozbatiran, Nuray AU - Sullivan, Jennifer L. AU - Paranjape, Ruta AU - Losey, Colin AU - Hernandez, Zachary AU - Keser, Zafer AU - Grossman, Robert AU - Francisco, Gerard AU - O’Malley, Marcia K. AU - Contreras-Vidal, Jose TI - A clinical trial to study changes in neural activity and motor recovery following brain-machine interface enabled robot-assisted stroke rehabilitation AID - 10.1101/2020.04.26.20077529 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.26.20077529 4099 - http://medrxiv.org/content/early/2020/05/01/2020.04.26.20077529.short 4100 - http://medrxiv.org/content/early/2020/05/01/2020.04.26.20077529.full AB - Background Brain-machine interfaces (BMI) based on scalp electroencephalography (EEG) have the potential to promote cortical plasticity following stroke, which has been shown to improve motor recovery outcomes. However, clinical efficacy of BMI-enabled robotic rehabilitation in chronic stroke population is confounded by the spectrum of motor impairments caused by stroke.Objective To evaluate the efficacy of neurorehabilitation therapy on upper-limb motor recovery, by quantifying changes in clinical, BMI-based, and kinematics-based metrics. Further, to identify neural correlates or biomarkers that can predict the extent of motor recovery.Methods Chronic stroke survivors (n = 10, age 55 ± 9.2y, chronicity 3.1 ± 2.8y) were recruited to participate in a 4-6 weeks long clinical study. Participants completed 12 therapy sessions that involved a BMI enabled powered exoskeleton (MAHI Exo-II) for training, which targeted elbow flexion and extension. Clinical assessments including Fugl-Meyer Upper Extremity (FMA-UE) and Action Research Arm Test (ARAT) were measured up to 2-months after therapy. BMI performance, kinematic performance, and change in movement related cortical potentials (MRCP) were also determined.Results On average, 132 ± 22 repetitions were performed per participant, per session. BMI accuracy across all sessions and subjects was 79 ± 18%, with a small number of false positives (23 ± 20%). FMA-UE and ARAT scores improved significantly over baseline after therapy and were retained at follow-ups (ΔFMA-UE = 3.92 ± 3.73 and ΔARAT = 5.35 ± 4.62, p < 0.05). 80% participants (7 with moderate-mild impairment and 1 with severe-moderate impairment) reached minimal clinically important difference (MCID: FMA-UE > 5.2 or ARAT > 5.7) during the course of the study. Kinematic measures indicate that, on average, participants’ movements became faster and smoother. Quantification of changes in MRCP amplitude showed significant correlation with ARAT scores (ρ = 0.72, p < 0.05) and marginally significant correlation with FMA-UE (ρ = 0.63, p = 0.051), suggesting higher activation of ipsi-lesional hemisphere post-intervention. The study did not have any adverse events.Conclusion This study presents evidence that BMI enabled robotic rehabilitation can promote motor recovery in individuals with chronic stroke, several years after injury and irrespective of their impairment level, or location of the lesion (cortical/subcortical) at baseline. Further, the extent of motor recovery was correlated with changes in movement related potentials, occurring contralateral to the impaired arm.Support NIH National Robotics Initiative Grant R01NS081854 and a grant from Mission Connect, a project of TIRR Foundation.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT01948739Funding StatementThis work was supported by NIH National Robotics Initiative Grant R01NS081854 and a grant from Mission Connect, a project of TIRR Foundation.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available from the corresponding author upon reasonable requests.